Disc Medicine, Inc.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: US2546041011

USD

93.79

4.07 (4.54%)

Dec 04

NAS

Click here to see other stocks

Company CV

About Disc Medicine, Inc.

stock-summary

Disc Medicine, Inc.

Pharmaceuticals & Biotechnology

FS Development Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company focuses for target business in the biotechnology sector. The Company has no business operations and has not generated any revenues.

Company Coordinates

Company Details

C/O Foresite Capital, 600 Montgomery St, Suite 4500 SAN FRANCISCO CA : 94111

stock-summary

Tel: 1 415 8774887

stock-summary

stock-summary

Registrar Details

Shareholding

Shareholding Snapshot

Shareholding Compare (%holding)

Majority shareholders

Strategic Entities

Domestic Funds

Held in 43 Schemes (32.47%)

Foreign Institutions

Held by 80 Foreign Institutions (9.6%)

Strategic Entities with highest holding

Highest Public shareholder

Board of Directors

Management

Designation

No Data

Stock DNA

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2025)

Net Profit:

-55 Million

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 2,152 Million ()

P/E

NA (Loss Making)

Industry P/E

NA

Dividend Yield

0.00%

Debt Equity

-1.01

Return on Equity

-23.67%

Price to Book

3.50